The potential use of miRNAs as biomarkers in complement-mediated renal pathologies

被引：0
|
作者：
Gutierrez-Tenorio, Josue [1 ]
Caravaca, Fernando [2 ]
Lucientes, Laura [1 ]
Llamas, Adara [1 ]
Marquez, Barbara [1 ]
Praga, Manuel [2 ]
Goicoechea de Jorge, Elena [1 ]
机构：
[1] Univ Complutense Madrid, Res Inst Hosp Octubre 12, Dept Immunol, Madrid, Spain
[2] Res Inst Hosp 12 Octubre Imas12, Dept Nephrol, Madrid, Spain
来源：
MOLECULAR IMMUNOLOGY | 2018年 / 102卷
关键词：
Complement system; Renal disease; MicroRNAs; Biomarkers;
D O I：
10.1016/j.molimm.2018.06.086
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
071
引用
收藏
页码：158 / 158
页数：1
相关论文
共 50 条
  • [41] COMPLEMENT-MEDIATED IMMUNE-MECHANISMS IN RENAL INFECTION .1. EFFECT OF RENAL TISSUE INVITRO
    ORMROD, DJ
    MILLER, TE
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1978, 33 (01): : 107 - 114
  • [42] How complement inhibitors are transforming the management of complement-mediated disorders
    Prata, Pedro H.
    de Latour, Regis Peffault
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2024,
  • [43] INTERACTION OF COLLAGEN WITH SERUM COMPLEMENT - INHIBITION OF COMPLEMENT-MEDIATED HEMOLYSIS
    TAKAHASHI, M
    KAWACHITAKAHASHI, S
    MATSUURA, M
    INTERNATIONAL ARCHIVES OF ALLERGY AND APPLIED IMMUNOLOGY, 1975, 48 (05): : 642 - 652
  • [44] Independent pathways of P-selectin and complement-mediated renal ischemia/reperfusion injury
    Farrar, CA
    Wang, Y
    Sacks, SH
    Zhou, WD
    AMERICAN JOURNAL OF PATHOLOGY, 2004, 164 (01): : 133 - 141
  • [45] COMPLEMENT-MEDIATED IMMUNE-MECHANISMS IN RENAL INFECTION .2. EFFECT OF DECOMPLEMENTATION
    MILLER, TE
    PHILLIPS, S
    SIMPSON, IJ
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1978, 33 (01): : 115 - 121
  • [46] Eculizumab in the treatment of atypical haemolytic uraemic syndrome and other complement-mediated renal diseases
    Nester, Carla M.
    Brophy, Patrick D.
    CURRENT OPINION IN PEDIATRICS, 2013, 25 (02) : 225 - 231
  • [47] Neuroprotection from complement-mediated inflammatory damage
    Kulkarni, AP
    Kellaway, LA
    Lahiri, DK
    Kotwal, GJ
    PROTECTIVE STRATEGIES FOR NEURODEGENERATIVE DISEASES, 2004, 1035 : 147 - 164
  • [48] Chemical Approaches to Modulating Complement-Mediated Diseases
    Iyer, Abishek
    Xu, Weijun
    Reid, Robert C.
    Fairlie, David P.
    JOURNAL OF MEDICINAL CHEMISTRY, 2018, 61 (08) : 3253 - 3276
  • [49] Targeting complement-mediated immunoregulation for cancer immunotherapy
    Kolev, Martin
    Markiewski, Maciej M.
    SEMINARS IN IMMUNOLOGY, 2018, 37 (0C) : 85 - 97
  • [50] COMPLEMENT-MEDIATED LYSIS WITH MONOCLONAL-ANTIBODIES
    HOWARD, J
    HUGHESJONES, N
    PROGRESS IN ALLERGY, 1988, 45 : 1 - 15
12345